Drug factory · FDA FEI 3005656362
Reckitt Benckiser Healthcare International Ltd
D95 Building, Nottingham, United Kingdom
Problems found, fixed voluntarily at FDA's last inspection, Dec 3, 2021.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2013: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Lanthanum Cation (3+) | Makes it | Prasco Laboratories, Takeda Pharmaceuticals America, Inc. | 66993-422, 66993-423, 66993-424 +3 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 3, 2021 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 13, 2013 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.